Skip to main content

Table 4 Odds ratio of LDL-C control at 6 months follow-up according to continuous or tertiles of SUA

From: Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction

SUA, μmol/L

N

Mean ± SD

Unadjusted model

Adjusted model 1

Adjusted model 2

OR(95%CI)

P value

OR(95%CI)

P value

OR(95%CI)

P value

SUA (per SD)

475

400.96 ± 120.58

1.83 (1.38, 2.43)

 < 0.001

2.14 (1.51, 3.04)

 < 0.001

2.21 (1.50, 3.26)

 < 0.001

Tertiles

 T1 (< 341.7)

158

277.18 ± 49.36

1

-

1

-

1

-

 T2(≥ 341.7, < 437.0)

158

390.00 ± 26.10

1.68 (0.68, 4.18)

0.263

1.86 (0.70, 4.99)

0.216

1.89 (0.67, 5.31)

0.229

 T3 (≥ 437.0)

159

534.86 ± 83.86

4.01 (1.77, 9.10)

 < 0.001

5.76 (2.19, 15.15)

 < 0.001

5.62 (2.05, 15.36)

 < 0.001

P for trend

   

 < 0.001

 

 < 0.001

 

 < 0.001

  1. Model 1 was adjusted for sex, BMI, age, hypertension, diabetes, smoke, drink, types of AMI, gout, TG, LDL-C, BUN, CRE, eGFR, AST, ALT, TBIL, statin use, uric acid lowering drugs, diuretics and β receptor blocker; Model 2 was adjusted for sex, BMI, age, hypertension, diabetes, smoke, drink, types of AMI, gout, TG, LDL-C, BUN, CRE, eGFR, AST, ALT, TBIL, statin use, uric acid lowering drugs, diuretics, β receptor blocker, LVEF, culprit vessel and Killip class
  2. SUA, serum uric acid; BMI, body mass index; AMI, acute myocardial infarction; SBP, systolic blood pressure; DBP, diastolic blood pressure; TBil, total bilirubin; DBIL, direct bilirubin; IBIL, indirect bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CRE, creatinine; eGFR, estimated glomerular filtration rate; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction